# A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3–1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-randomized-open-label-multicenter-phase-ii-study-evaluating-the-efficacy-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Michael Thomas,Parvis Sadjadian,Jens Kollmeier,Jamie Lowe,Paulette Mattson,J. Richard Trout,Michele Gargano,Myra L. Patchen,Richard M. Walsh,Martin Béliveau,Jean‐Francois Marier,Nandita Bose,Keith Gorden,Folker Schneller |
| Citations | 53 |
| DOI | 10.1007/s10637-017-0450-3 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007%2Fs10637-017-0450-3.pdf |
| OpenAlex ID | https://openalex.org/W2597378792 |
| PMID | 28303530 |
| Type | article |
| Year | 2017 |

## Paper authors

- [J. Richard Trout](https://scholariq.org/researchers/j-richard-trout/)

## Paper journal

- [Investigational New Drugs](https://scholariq.org/journals/investigational-new-drugs/)

## Paper primary topic

- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)

## Paper topics

- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.